Esteve laboratory licenses a medicine for the treatment of pain in the US, developed in-house by R&D team

Esteve has new plans for the E-58425a drug for the treatment of pain that, at the time, aspired to become a best-seller. The pharmaceutical company has reached an agreement to license it with Kowa Pharmaceuticals in the US and is currently in the registration phase in Spain, Italy and Portugal.